Orchard Therapeutics plc Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Orchard Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$35.3M, a 25.7% increase year-over-year.
  • Orchard Therapeutics plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$72.9M, a 59.3% increase year-over-year.
  • Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$151M, a 4.2% decline from 2021.
  • Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2021 was -$145M, a 4.87% increase from 2020.
  • Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2020 was -$152M, a 7% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$151M -$6.08M -4.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 -$145M +$7.4M +4.87% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$152M +$11.4M +7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$163M +$67.1M +29.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$230M -$191M -480% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$39.7M -$20.7M -108% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$19.1M Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.